Valve-in-Valve Therapy for Failed Surgical Bioprosthetic Valves: Clinical Results and Procedural Guidance [0.03%]
生物瓣膜衰败的瓣中瓣治疗：临床结果和操作指南
Alia Noorani,Vinayak Bapat
Alia Noorani
With improved life expectancy and increased use of bioprosthetic heart valves, more elderly and frail patients present with degenerative surgical heart valve disease. The valve-in-valve procedure is an attractive alternative to a convention...
Risk Assessment in Patient Selection for Transcatheter Aortic Valve Replacement [0.03%]
经导管主动脉瓣植入术的患者选择风险评估
Joseph A Walsh rd,Paul S Teirstein,Curtiss Stinis et al.
Joseph A Walsh rd et al.
Risk assessment models for transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement in high-risk patients and TAVR versus palliation in inoperable patients are based on surgical data and have limited discrimina...
Howard A Cohen,Jose P S Henriques
Howard A Cohen
Tim Lockie,Simon Redwood
Tim Lockie
Outcomes of patients in cardiogenic shock remain high, but the development of novel percutaneous mechanical circulatory support devices offers additional therapeutic options. Hand in hand with innovations in device technology, however, must...
Hammad Saudye,Kirk N Garratt
Hammad Saudye
Improving myocyte salvage during acute myocardial infarction (AMI) has proved elusive; the keys to success seem to be the ability to lower oxygen demand of ischemic myocardium and also activate salvage enzyme pathways to take advantage of e...
Sukhdeep S Basra,Pranav Loyalka,Igor Gregoric et al.
Sukhdeep S Basra et al.
Percutaneous ventricular assist devices (PVADs) are increasingly being used for hemodynamic support in patients with cardiogenic shock as well as for patients undergoing high-risk cardiovascular procedures. The currently available PVADs for...
Navin K Kapur,Yousef H Bader
Navin K Kapur
Heart failure is a major cause of global morbidity and mortality affecting nearly 24 million individuals worldwide. Although the importance of right ventricular (RV) function has become more apparent over the past few decades, few therapies...
Vegard Tuseth
Vegard Tuseth
Persistent cardiac arrest is often caused by coronary ischemia. Urgent revascularization during on-going resuscitation with the support of percutaneous left ventricular assist devices (PVAD) may be feasible and can have the potential to imp...
Usage of Percutaneous Left Ventricular Assist Devices in Clinical Practice and High-risk Percutaneous Coronary Intervention [0.03%]
经皮左心室辅助装置的临床应用及高危经皮冠状动脉介入治疗中的使用
Juan N Pulido,Charanjit S Rihal
Juan N Pulido
Patients who require coronary revascularization and present with poor left ventricular function and complex coronary anatomy are at high risk for percutaneous coronary intervention (PCI) and coronary artery bypass grafting surgery. Some of ...
Hemodynamic Support: Science and Evaluation of the Assisted Circulation with Percutaneous Assist Devices [0.03%]
血流动力学支持：经皮辅助装置的辅助循环科学与评估
Daniel Burkhoff
Daniel Burkhoff
Pathophysiologic mechanisms that lead to hemodynamic abnormalities in cardiogenic shock (including hypotension, hypoperfusion, and elevated venous pressures) are reviewed within the framework of pressure-volume analysis. This approach provi...